BACKGROUND Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of
cancer therapy. The goal of this systematic review was to update the Multinational …

Glutamine is a major dietary amino acid that is both a fuel and nitrogen donor for healing
tissues damaged by chemotherapy and radiation. Evidence supports the benefit of oral …

Purpose Hematology–oncology patients undergoing chemotherapy and hematopoietic stem
cell transplantation (HSCT) recipients are at risk for oral complications which may cause …

Oral mucositis is a common side-effect associated with conventional cancer therapy and has
also recently been reported in association with newly emerging cancer therapies. It is …

An estimated 1.6 million people receive cancer therapy in the United States each year and
worldwide numbers are much higher. 1 Although advancements in cancer therapy improved …

Background Oral mucositis (OM) due to radiotherapy and systemic therapies in head and
neck cancer treatment represents a major problem causing a wide spectrum of clinical signs …

Abstract Purpose To update the 2013 Multinational Association of Supportive Care in
Cancer/International Society of Oral Oncology (MASCC/ISOO) clinical practice guidelines on …

Oral mucositis is a condition that is characterized by ulcerative lesions in the mucosa of
patients undergoing radiotherapy or chemotherapy. Oral mucositis is currently considered to …

Purpose To update the 2015 clinical practice guideline for the prevention of oral mucositis in
pediatric cancer or hematopoietic stem cell transplant (HSCT) patients. Methods We …

Many studies show that the human microbiome plays a critical role in the chronic
pathologies of obesity, inflammatory bowel diseases, and diabetes. More recently, the …